Clinical research

A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry

EuroIntervention 2012;7:1293-1300. DOI: 10.4244/EIJV7I11A204

Pierfrancesco Agostoni
Pierfrancesco Agostoni1, MD PhD; David Foley², MD PhD; Maciej Lesiak3, MD PhD; Anouar Belkacemi1, MD; Jo Dens4, MD PhD; Indulis Kumsars5, MD; Benjamin Scott6, MD; Pranobe Oemrawsingh7, MD PhD; Christophe Dubois8, MD PhD; Eulogio Garcia9, MD; Thierry Lefèvre10, MD; Pieter R. Stella1*, MD PhD
1. University Medical Center, Utrecht, The Netherlands; 2. Beaumont Hospital, Dublin, Ireland; 3. Poznań University Hospital, Poznań, Poland; 4. Oost-Limburg Hospital, Genk, Belgium; 5. Latvian Center of Cardiology, Paul Stradins Clinic

Aims: The percutaneous treatment of coronary bifurcation lesions remains hampered by suboptimal results, mainly in the side branch (SB), even wi

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

bifurcationangioplastydedicated stentdrug-eluting stents
Read next article
Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial

Latest news